BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4383294)

  • 1. Drug responses of three hospital population samples participating in a collaborative study.
    Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T
    Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294
    [No Abstract]   [Full Text] [Related]  

  • 2. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 4. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 5. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 7. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 9. [First clinical trails with the "medium tranquilizer" mesoridazine].
    Rhomberg F; Staehelin B
    Schweiz Med Wochenschr; 1967 Apr; 97(16):521-5. PubMed ID: 4875573
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 11. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies with propericiazine (R.P. 8909).
    St Jean A; Sterlin C; Noe W; Ban TA
    Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
    [No Abstract]   [Full Text] [Related]  

  • 13. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes in chronic schizophrenia.
    Marinow A
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of lobotomized schizophrenic patients with butaperazine.
    Holden JM; Itil TM; Keskiner A
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):418-28. PubMed ID: 4390417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of Navane concentrate and tablets].
    Radmayr E
    Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):340-60. PubMed ID: 4241209
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.